(1)
Orally Administered Fisetin As an Immuno-Modulatory and Therapeutic Agent in a Mouse Model of Chronic Allergic Airway Disease. Biomed. Res. Ther. 2019, 6 (7), 3262-3273. https://doi.org/10.15419/bmrat.v6i7.553.